Loading insider details...
Latest Form 4 (Aug 13, 2026): Exercise/Conversion of 41,494 MRK shares, $4.89M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 41,494 | $4.89M |
| Jun 2, 2026 | REGENXBIO Inc. (RGNX) | Grant/Award | 9,807 | n/a |
| May 7, 2026 | Merck & Co., Inc. (MRK) | Grant/Award | 12,064 | n/a |
| May 1, 2026 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 2,951 | $324.7K |
| Feb 9, 2026 | Merck & Co., Inc. (MRK) | Exercise/Conversion | 25,946 | $3.09M |
| Jan 28, 2026 | Merck & Co., Inc. (MRK) | Grant/Award | 11,583 | $1.24M |
| Jun 3, 2025 | REGENXBIO Inc. (RGNX) | Grant/Award | 7,768 | n/a |
| May 1, 2025 | Merck & Co., Inc. (MRK) | Grant/Award | 8,854 | n/a |
| Jan 29, 2025 | Merck & Co., Inc. (MRK) | Grant/Award | 25,423 | $2.49M |
| Jun 4, 2024 | REGENXBIO Inc. (RGNX) | Grant/Award | 4,790 | n/a |